TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.

Ighovwerha Ofotokun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.